✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (234 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
37.64
4,32,096
68.76
1,48,718
29.12
1,12,971
25.92
1,08,752
21.52
1,08,442
19.48
1,03,900
51.32
98,179
23.49
82,331
180
69,415
28.56
65,734
60.26
64,180
36.80
57,112
33.64
38,383
36.12
37,417
34.43
36,359
49.16
34,881
154
32,997
34.67
32,051
115
21,679
29.13
21,042
-
20,803
31.27
19,374
32.16
19,137
12.84
18,211
123
16,575
24.06
15,431
21.41
14,449
42.43
13,667
31.25
12,533
63.84
11,317
26.69
11,155
42.06
10,973
49.06
10,777
41.00
10,573
55.32
10,241
18.38
10,223
30.69
10,034
40.04
9,743
48.45
8,377
32.33
8,251
-
7,367
23.10
7,155
4.43
6,877
23.35
6,571
44.63
5,149
34.49
4,860
34.80
4,494
94.33
4,403
24.18
4,080
195
4,010
-
3,897
27.44
3,777
31.71
3,652
17.86
3,481
33.95
3,462
67.12
3,358
-
2,526
9.75
2,465
35.60
2,397
25.01
2,373
7.11
2,256
151
2,162
-
1,935
58.13
1,772
35.78
1,722
25.84
1,717
16.68
1,715
30.59
1,702
27.93
1,618
38.20
1,585
18.48
1,413
32.17
1,386
42.17
1,376
5.32
1,321
44.06
1,277
57.81
1,274
21.10
1,267
14.40
1,266
39.36
1,107
24.84
1,068
24.17
1,060
47.64
1,015
885
1,013
38.72
996
-
927
43.74
877
12.11
869
36.20
844
46.94
834
18.77
771
36.22
743
20.99
633
32.27
587
28.19
579
27.58
555
93.86
548
25.74
511
14.63
508
32.53
484
23.82
472
-
424
-
402
30.24
397
38.02
367
35.31
319
68.79
318
64.57
317
32.80
317
15.64
298
16.57
286
16.24
286
15.36
274
-
273
25.19
268
44.70
261
-
252
45.29
242
-
241
21.08
230
63.34
218
-
208
19.14
207
-
194
40.52
194
8.97
194
14.13
192
28.96
192
15.42
190
37.35
189
14.04
183
26.35
179
58.51
173
17.97
173
660
171
12.08
169
-
169
13.94
164
90.60
164
7.91
155
33.97
153
12.81
149
14.87
146
16.88
145
22.87
144
23.76
144
41.29
141
20.87
140
-
139
14.11
136
31.49
129
21.27
123
102
109
-
107
27.84
104
11.63
101
41.10
97
15.63
95
19.42
92
-
92
11.48
82
-
77
-
76
46.18
72
-
71
20.84
71
317
71
-
65
6.10
65
14.37
62
13.54
61
13.46
58
20.61
57
-
55
5.98
54
2.98
53
-
53
16.98
53
11.96
50
21.52
50
121
49
60.30
48
16.41
47
-
46
-
45
99.65
44
-
42
26.14
41
20.97
41
50.86
39
18.46
37
-
36
10.90
33
-
33
26.37
32
13.97
32
13.31
31
8.89
30
6.16
30
7.21
29
112
28
20.99
27
-
27
-
27
320
27
6.17
26
12.36
26
77.38
23
25.22
22
-
21
31.61
20
-
17
38.39
17
-
14
26.26
13
-
13
12.63
13
-
13
163
12
-
12
28.32
12
813
11
-
9
12.39
9
60.93
9
859
8
-
8
-
8
65.07
7
89.76
7
-
5
-
5
69.81
4
-
3
-
2
Showing 5 234 of 234 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material